Determination of cerebral blood flow velocity and microembolic signals in essential thrombocytosis by transcranial doppler ultrasonography

References

• Harrison CN. Current trends in essential thrombocythaemia. Br J Haematol. 2002;117(4):796–808.
   PubMed Web of Science ®Google Scholar
• Tefferi A. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview. Mayo Clin Proc. 1998;73(12):1177–1184.
   PubMed Web of Science ®Google Scholar
• Mesa RA, Silverstein MN, Jacobsen SJ, et al. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol. 1999;61(1):10–15.
   PubMed Web of Science ®Google Scholar
• Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2005;128(3):275–290.
   PubMed Web of Science ®Google Scholar
• Bazzan M, Tamponi G, Schinco P, et al. Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia. Ann Hematol. 1999;78(12):539–543.
   PubMed Web of Science ®Google Scholar
• Jabaily J, Iland HJ, Laszlo J, et al. Neurologic manifestations of essential thrombocythemia. Ann Intern Med. 1983;99(4):513–518.
   PubMed Web of Science ®Google Scholar
• Rocca B, Ciabattoni G, Tartaglione R, et al. Increased thromboxane biosynthesis in essential thrombocythemia. Thromb Haemost. 1995;74(5):1225–1230.
   PubMed Web of Science ®Google Scholar
• Harrison CN, Campbell PJ, Buck G, et al. United Kingdom Medical Research Council primary thrombocythemia 1 study. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med. 2005;353(1):33–45.
   PubMed Web of Science ®Google Scholar
• Finazzi G, Barbui T. Risk-adapted therapy in essential thrombocythemia and polycythemia vera. Blood Rev. 2005;19(5):243–252.
   PubMed Web of Science ®Google Scholar
• Passamonti F, Rumi E, Arcaini L, et al. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica. 2008;93(11):1645–1651.
   PubMed Web of Science ®Google Scholar
• Posfai E, Marton I, Szőke A, et al. Stroke in essential thrombocythemia. J Neurol Sci. 2014;336(1–2):260–262.
   PubMed Web of Science ®Google Scholar
• D’Andrea A, Conte M, Cavallaro M, et al. Transcranial doppler ultrasonography: from methodology to major clinical applications. World J Cardiol. 2016;8(7):383–400.
   PubMed Web of Science ®Google Scholar
• Lau AY, Zhao Y, Chen C, et al. (CLAIR study investigators.) Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: subgroup analysis of CLAIR study. Int J Stroke. 2014;9(Suppl A100):127–132.
   PubMed Web of Science ®Google Scholar
• Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997;42(5):699–704.
   PubMed Web of Science ®Google Scholar
• Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.
   PubMed Web of Science ®Google Scholar
• Blaser T, Krueger S, Kross R, et al. Acetylsalicylic acid induced cessation of transient ischaemic attacks and microembolic signals detected by transcranial Doppler in a patient with essential thrombocythaemia. J Neurol. 2001;248(1):67–68.
   PubMed Web of Science ®Google Scholar
• Asil T, Utku U, Balci K, et al. Changing cerebral blood flow velocity by transcranial Doppler during head up tilt in patients with diabetes mellitus. Clin Neurol Neurosurg. 2007;109(1):1–6.
   PubMed Web of Science ®Google Scholar
• Kılıc K, Tumer B, Keser N, et al. Transkranial Dopler ve Nöroşirürjide Klinik Uygulamaları. Türk Nöroşirürji Dergisi. 1993;3:67–79.
   Google Scholar
• Ritter MA, Jurk K, Schriek C, et al. Microembolic signals on transcranial Doppler ultrasound are correlated with platelet activation markers, but not with platelet-leukocyte associates: a study in patients with acute stroke and in patients with asymptomatic carotid stenosis. Neurol Res. 2009;31(1):11–16.
   PubMed Web of Science ®Google Scholar
• Warsz-Wianecka A, Lasek-Bal A, Kazibutowska Z. Cerebral microembolism in patients with segmental left ventricular wall motion abnormalities. Neurol Neurochir Pol. 2014;48(2):98–104.
   PubMed Web of Science ®Google Scholar
• Tong DC, Gregory W. Transranial doppler detected microemboli in patients with acute stroke. Am Stroke Asoc. 1995;26:1588–1592.
   PubMed Web of Science ®Google Scholar
• Goertler M, Baeumer M, Kross R, et al. Rapid decline of cerebral microemboli of arterial origin after intravenous acetylsalicylic acid. Stroke. 1999;30(1):66–69.
   PubMed Web of Science ®Google Scholar
• Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111(17):2233–2240.
   PubMed Web of Science ®Google Scholar
• Stroobant N, Vingerhoets G. Test-retest reliability of functional transcranial Doppler ultrasonography. Ultrasound Med Biol. 2001;27:509–514.
   PubMed Web of Science ®Google Scholar
• Sharma VK, Tsivgoulis G, Lao AY, et al. Noninvasive detection of diffuse intracranial disease. Stroke. 2007;38:3175–3181.
   PubMed Web of Science ®Google Scholar
• Park KY, Chung PW, Kim YB, et al. Increased pulsatility index is associated with intracranial arterial calcification. Eur Neurol. 2013;69(2):83–88.
   PubMed Web of Science ®Google Scholar
• Cetin G, Ozkan T, Turgut S, et al. Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. Mol Biol Rep. 2014;41(10):6737–6742.
   PubMed Web of Science ®Google Scholar
• Takata Y, Seki R, Kanajii T, et al. Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms. Kurume Med J. 2014;60(3–4):89–97.
   PubMedGoogle Scholar